Bionano Genomics (BNGO) Acquisitions (2021 - 2022)

Bionano Genomics' (BNGO) quarterly Acquisitions came in at $32.0 million in Q4 2022, down 34.73% year-on-year from $49.1 million in Q4 2021, and up 4716.43% quarter-over-quarter from -$694000.0 in Q1 2022.

Bionano Genomics (BNGO) Acquisitions (2021 - 2022) Analysis & Trends

Bionano Genomics has disclosed Acquisitions across 2 years of filings, most recently posting $32.0 million for Q4 2022.

  • Acquisitions for Q4 2022 came in at $32.0 million, down 34.73% year-over-year; the trailing twelve-month figure through Dec 2022 was $31.3 million (down 36.14% YoY), and the FY2022 annual result was $31.3 million, down 36.14% from the prior year.
  • Acquisitions came in at $32.0 million for Q4 2022 at Bionano Genomics, up from -$694000.0 in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $49.1 million in Q4 2021 to a low of -$694000.0 in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 528.20 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 24.88 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 18.96 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -
10 Bionano Genomics 14.01 Mn -366,620.40 3.25 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 32.04 Mn
Mar 31, 2022 -694,000.00
Dec 31, 2021 49.09 Mn